Zobrazeno 1 - 10
of 32
pro vyhledávání: '"YOSHITAKA TOMIYAMA"'
Autor:
Yoshitaka Tomiyama, Makoto Murakami, Kohichi Hayakawa, Katsuyoshi Akiyama, Yoshinobu Yamazaki, Masami Kojima, Nobuo Shibata, Masuo Akahane
Publikováno v:
Journal of Pharmacological Sciences, Vol 92, Iss 4, Pp 411-419 (2003)
Since, in the human ureter, both β2- and β3-adrenoceptors mediate adrenergic-stimulation-induced relaxation, selective β2-/β3-adrenoceptor agonists might prove clinically useful for relieving ureteral colic and promoting stone passage. We evaluat
Externí odkaz:
https://doaj.org/article/06363c70edbd48bf866b9f1e881497f3
Autor:
Kazuyasu Maruyama, Itaru Maruyama, Yoshitaka Tomiyama, Osamu Yamaguchi, Mamoru Kobayashi, Yoshiaki Goi, Masanori Nomiya, Satoshi Tatemichi
Publikováno v:
Pharmacology. 97:161-170
Background/Aims: This study was performed to investigate the detailed mechanism underlying the effects of the selective α1A-adrenoceptor antagonist, silodosin, on bladder function in a rat model of atherosclerosis-induced chronic bladder ischemia (C
Autor:
Yoshitaka Tomiyama, Kazuyasu Maruyama, Ayaka Yokoyama, Mamoru Kobayashi, Osamu Yamaguchi, Satoshi Tatemichi, Yoshiaki Goi
Publikováno v:
European Journal of Pharmacology. 764:489-496
This study was performed to investigate the effects of silodosin (selective α1A-adrenoceptor antagonist) on bladder blood flow (BBF) and bladder function in a rat model of bladder outlet obstruction (BOO) and to determine the expression of α1-adren
Publikováno v:
Journal of Urology. 190:1116-1122
We investigated the effects of the selective α1A-adrenoceptor antagonist silodosin on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction.The chronic bladder i
Autor:
Yoshinobu Yamazaki, Yoshitaka Tomiyama, Mamoru Kobayashi, Satoshi Tatemichi, Shinya Kobayashi, Yuji Hoyano
Publikováno v:
European Journal of Pharmacology. 613:135-140
We examined whether the effects (efficacy on the urethra and hypotension) of silodosin (alpha(1A)-adrenoceptor antagonist) and tamsulosin (alpha(1A+1D)-adrenoceptor antagonist) in dogs with benign prostatic hyperplasia altered with age. We used young
Autor:
Yasue Kubota, Yoshitaka Tomiyama, Yoshinobu Yamazaki, Hiroshi Kusama, Kenjiro Kohri, Yasunori Itoh, Yuji Hoyano, Shinya Kobayashi
Publikováno v:
World Journal of Urology. 27:775-780
This study was performed to characterize the α1-adrenoceptor subtypes in mouse ureters as regards gene expressions and contractile functions.The mRNAs for these subtypes were quantified by the real-time quantitative reverse transcription polymerase
Autor:
Yoshinobu Yamazaki, Hiroshi Kusama, Shinya Kobayashi, Yuji Hoyano, Kazuyasu Maruyama, Yoshitaka Tomiyama
Publikováno v:
Journal of Smooth Muscle Research. 45:187-195
To compare the efficacy of the selective alpha(1A)-adrenoceptor antagonist silodosin with those of doxazosin, terazosin, and alfuzosin against alpha-adrenoceptor agonist-induced contractions in mouse and hamster ureters.The four alpha(1)-adrenoceptor
Autor:
Yoshiaki, Goi, Yoshitaka, Tomiyama, Itaru, Maruyama, Satoshi, Tatemichi, Kazuyasu, Maruyama, Mamoru, Kobayashi, Masanori, Nomiya, Osamu, Yamaguchi
Publikováno v:
Pharmacology. 97(3-4)
This study was performed to investigate the detailed mechanism underlying the effects of the selective α(1A)-adrenoceptor antagonist, silodosin, on bladder function in a rat model of atherosclerosis-induced chronic bladder ischemia (CBI).The CBI mod
Autor:
Itaru Maruyama, Yoshinobu Yamazaki, Kumi Kobayashi, Ayaka Maezawa, Mamoru Kobayashi, Satoshi Tatemichi, Yoshitaka Tomiyama, Nobuo Shibata, Shinya Kobayashi
Publikováno v:
Neurourology and Urodynamics. 25:792-799
Aims Our main aim was to compare the prostatic selectivity of silodosin with that of other α1-adrenoceptor (AR) antagonists. Methods We examined uroselectivities in two sets of experiments namely, in vitro and in vivo functional studies using male d
Autor:
Yoshinobu Yamazaki, Satoshi Tatemichi, Mariko Tadachi, Mamoru Kobayashi, Yoshitaka Tomiyama, Nobuo Shibata, Morimichi Hayashi, Shinya Kobayashi
Publikováno v:
YAKUGAKU ZASSHI. 126:225-230
We compared the urethral and cardiovascular eSects of silodosin (selective a1A-adrenoceptor antagonist) ,an ovel medication for benign prostatic hyperplasia (BPH), with those of tamsulosin (selective a1A/a1D-adrenoceptor antagonist) and naftopidil (s